CareDx, Inc (NASDAQ:CDNA) Investor Alert: Investigation Over Potential Wrongdoing

An investigation on behalf of investors in CareDx, Inc (NASDAQ:CDNA) shares over potential wrongdoing at CareDx, Inc was announced and NASDAQ:CDNA stockholders should contact the Shareholders Foundation.

San Diego, CA — (SBWIRE) — 01/12/2022 — An investigation on behalf of current long-term investors in shares of CareDx, Inc (NASDAQ: CDNA) was announced over potential breaches of fiduciary duties by certain officers and directors at CareDx, Inc.

Investors who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm concerns whether certain CareDx, Inc directors breached their fiduciary duties and caused damage to the company and its shareholders.

Brisbane, CA based CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic solutions for transplant patients worldwide.

On January 25, 2021, CareDx, Inc sold 1,923,077 shares of its common stock through an underwritten public offering at a public offering price of $91.00 per share.

On October 28, 2021, after the market closed, transplant diagnostics company, CareDx, Inc. released Q3 2021 financial results in which the Company disclosed it is being investigated by the U.S. Department of Justice (“DOJ”) related to its kidney testing and phlebotomy services. The Company is also being investigated by the U.S. Securities and Exchange Commission (“SEC”) for similar issues as well as certain accounting and public reporting practices, and the Company received an information request from an unnamed state agency.

Shares of CareDx, Inc (NASDAQ: CDNA) declined from $96.84 per share in June 2021, to as low as $40.31 per share on December 14, 2021.

Those who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit: http://www.sbwire.com/press-releases/caredx-inc-nasdaqcdna-investor-alert-investigation-over-potential-wrongdoing-1351664.htm

Media Relations Contact

Michael Daniels
Shareholders Foundation
Telephone: 1-858-779-1554
Email: Click to Email Michael Daniels
Web: https://www.shareholdersfoundation.com/